معرفی
Dr. Josée Hébert is a Full Professor at the Faculty of Medicine, Université de Montréal and holder of the Industrial-Alliance Chair in Leukemia Research. She leads the Quebec Leukemia Cell Bank (BCLQ), a provincial infrastructure since 2003, and is affiliated with the Maisonneuve-Rosemont Hospital Research Center (CRHMR) and the Immunology and Cancer Research Institute (IRIC). As a hematologist at HMR, she integrates clinical care with research in acute myeloid leukemia (AML).
Her research focuses on precision medicine in AML, including genomic sequencing of 700+ Quebec samples to identify prognostic markers and therapeutic targets. The Leucegene group, a multidisciplinary team, employs transcriptomics, proteomics, and chemogenomics to stratify AML subtypes. Key projects include high-throughput drug screening and surfaceome analysis for targeted therapies.
- Awards: 2017 Génome Canada Prize for precision genomics research (with Guy Sauvageau).
Dr. Hébert has secured major grants from Génome Canada, Terry Fox Research Institute, and Cole Foundation. She supervises graduate students and collaborates on translational projects like engineered hematopoietic stem cell therapies and biomarker-driven treatment strategies.
Her lab integrates clinical data with molecular profiling to improve risk-adapted therapies, emphasizing collaboration across institutions like McGill University and Université Laval.
